CEO David Mann will present "CAR Peptide, a Disease Selective Therapeutic Adjuvant For Targeted Drug Therapy" during the 7th Annual Therapeutic Peptide Symposium hosted at The Salk Institute in La Jolla, CA on October 25th and 26th.
Read MorePre-diabetes places Baldwin among an estimated 79 million Americans with elevated blood sugar levels that can put them at risk of chronic, life-threatening Type 2 diabetes, according to the American Diabetes Association.
Read More